MACMIROR COMPLEX*12 VAG SUPPOSITORIES

MACMIROR COMPLEX 500 mg/200,000 I.U. vaginal ovules
Nifuratel and Nystatin

What it is and what it is used for
MACMIROR COMPLEX contains the active ingredients nifuratel and nystatin.
Nifuratel is an antibacterial, mycostatic, and trichomonacidal agent, meaning it can inhibit the growth of organisms such as bacteria, fungi, yeasts, and protozoa.
Nystatin is an antibiotic with fungicidal action, meaning it can kill fungi.
MACMIROR COMPLEX is used in women for the treatment of genital infections (vulvovaginitis) caused by microorganisms such as Candida, Trichomonas, and bacteria.
The most common symptoms of such infections are: abundant and/or unusual vaginal discharge, itching, redness, burning, burning during urination, and pain during sexual intercourse.
Consult your doctor if you do not feel better or if you feel worse.

What you need to know before taking the medicine
Do not use MACMIROR COMPLEX
- if you are allergic to nifuratel and/or nystatin or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions
Talk to your doctor or pharmacist before using MACMIROR COMPLEX.
The use of topical products, especially if prolonged, can cause allergic reactions (see section Possible side effects). In this case, stop the treatment and consult your doctor, who will institute appropriate therapy.

MACMIROR COMPLEX is for local vaginal use only. Do not swallow.

Children
This medicine is not recommended for young girls because its safety and efficacy have not been demonstrated.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.